Clinical trial
An Open-Label, Single-Arm, Multi-Center Study of TG-873870 for Treating Patients With Diabetic Foot Infections of Mild to Moderate Severity Associated With Gram-Positive Pathogens
NCT00685698 is registered in ClinicalTrials.gov with TaiGen Biotechnology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Single-Arm, Multi-Center Study of TG-873870 for Treating Patients With Diabetic Foot Infections of Mild to Moderate Severity Associated With Gram-Positive Pathogens
- Lead sponsor
- TaiGen Biotechnology Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- June 30, 2009
- Enrollment
- 40 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot infections